NG
LLY icon

Norden Group’s Eli Lilly LLY Stock Holding History

Norden Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.79M Sell
7,327
-2,090
-22% -$2.14M 0.72% 29
2026
Q1 		$8.66M Buy
9,417
+252
+3% +$255K 0.83% 22
2025
Q4 		$9.85M Buy
9,165
+313
+4% +$299K 0.96% 16
2025
Q3 		$6.75M Buy
8,852
+83
+0.9% +$61.8K 0.69% 31
2025
Q2 		$6.84M Buy
8,769
+59
+0.7% +$45.8K 0.74% 22
2025
Q1 		$7.19M Buy
8,710
+1,717
+25% +$1.43M 0.83% 15
2024
Q4 		$5.4M Buy
6,993
+3,054
+78% +$2.53M 0.61% 32
2024
Q3 		$3.49M Buy
3,939
+1,859
+89% +$1.67M 0.41% 60
2024
Q2 		$1.88M Buy
2,080
+27
+1% +$21.6K 0.38% 59
2024
Q1 		$1.6M Buy
2,053
+371
+22% +$264K 0.32% 70
2023
Q4 		$980K Sell
1,682
-35
-2% -$20.4K 0.17% 74
2023
Q3 		$922K Buy
+1,717
New +$885K 0.3% 75

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norden Group's LLY Position: Q2 2026 in Review

Norden Group reduced its Eli Lilly (LLY) stake by 22% in Q2 2026, selling an estimated $2.14M and leaving 7,327 shares worth $8.79M. The position accounts for 0.72% of the portfolio, ranked #29.

Norden Group first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $9.85M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Norden Group held 7,327 shares of Eli Lilly worth $8.79M as of Q2 2026.
  • Norden Group sold 2,090 Eli Lilly shares in Q2 2026, an estimated $2.14M.
  • Eli Lilly made up 0.72% of Norden Group's portfolio in Q2 2026, its #29 holding.
  • Norden Group first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • Norden Group's Eli Lilly position peaked at $9.85M in Q4 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.